(R)-pantothenic acid increases expression ISO RGD:1344499 6480464 Pantothenic Acid results in increased expression of MYCN mRNA CTD PMID:19397697 1,2-dichloroethane decreases expression ISO RGD:1614446 6480464 ethylene dichloride results in decreased expression of MYCN mRNA CTD PMID:28189721 , PMID:28960355 17alpha-ethynylestradiol increases expression EXP 6480464 Ethinyl Estradiol results in increased expression of MYCN mRNA CTD PMID:15576828 17alpha-ethynylestradiol affects expression EXP 6480464 Ethinyl Estradiol affects the expression of MYCN mRNA CTD PMID:20170705 , PMID:26865667 17alpha-ethynylestradiol affects expression ISO RGD:1344499 6480464 Ethinyl Estradiol affects the expression of MYCN mRNA CTD PMID:20170705 , PMID:26865667 17alpha-ethynylestradiol decreases expression ISO RGD:1344499 6480464 Ethinyl Estradiol results in decreased expression of MYCN mRNA CTD PMID:18936297 17alpha-ethynylestradiol increases expression ISO RGD:1614446 6480464 Ethinyl Estradiol results in increased expression of MYCN mRNA CTD PMID:17942748 17beta-estradiol multiple interactions ISO RGD:1344499 6480464 [Progesterone co-treated with Estradiol] results in decreased expression of MYCN mRNA CTD PMID:17404688 17beta-estradiol decreases expression ISO RGD:1344499 6480464 Estradiol results in decreased expression of MYCN mRNA CTD PMID:31614463 17beta-estradiol multiple interactions EXP 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of MYCN mRNA CTD PMID:32741896 17beta-estradiol 3-benzoate multiple interactions EXP 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of MYCN mRNA CTD PMID:32741896 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions ISO RGD:1614446 6480464 [2 more ... CTD PMID:25510870 2,2',5,5'-tetrachlorobiphenyl increases expression EXP 6480464 2 more ... CTD PMID:23829299 2,2',5,5'-tetrachlorobiphenyl multiple interactions ISO RGD:1614446 6480464 [2 more ... CTD PMID:25510870 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1614446 6480464 Tetrachlorodibenzodioxin results in decreased expression of MYCN mRNA CTD PMID:17035482 more ... 2-methylcholine affects expression ISO RGD:1344499 6480464 beta-methylcholine affects the expression of MYCN mRNA CTD PMID:21179406 3,4-methylenedioxymethamphetamine decreases expression ISO RGD:1614446 6480464 N-Methyl-3, 4-methylenedioxyamphetamine results in decreased expression of MYCN mRNA CTD PMID:20188158 4,4'-diaminodiphenylmethane increases expression ISO RGD:1614446 6480464 4, 4'-diaminodiphenylmethane results in increased expression of MYCN mRNA CTD PMID:18648102 5-fluorouracil decreases expression ISO RGD:1614446 6480464 Fluorouracil results in decreased expression of MYCN mRNA CTD PMID:19272435 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of MYCN mRNA CTD PMID:24780913 Aflatoxin B2 alpha decreases methylation ISO RGD:1344499 6480464 aflatoxin B2 results in decreased methylation of MYCN intron CTD PMID:30157460 all-trans-retinoic acid multiple interactions ISO RGD:1344499 6480464 R116010 promotes the reaction [Tretinoin results in decreased expression of MYCN mRNA] CTD PMID:17486130 all-trans-retinoic acid decreases expression ISO RGD:1614446 6480464 Tretinoin results in decreased expression of MYCN mRNA CTD PMID:16604517 all-trans-retinoic acid decreases expression ISO RGD:1344499 6480464 Tretinoin results in decreased expression of MYCN, Tretinoin results in decreased expression of MYCN mRNA CTD PMID:17229153 more ... ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of MYCN mRNA CTD PMID:16483693 antirheumatic drug increases expression ISO RGD:1344499 6480464 Antirheumatic Agents results in increased expression of MYCN mRNA CTD PMID:24449571 Aroclor 1254 decreases expression ISO RGD:1614446 6480464 Chlorodiphenyl (54% Chlorine) results in decreased expression of MYCN mRNA CTD PMID:25270620 arsenite(3-) decreases expression ISO RGD:1614446 6480464 arsenite results in decreased expression of MYCN mRNA CTD PMID:18929588 arsenite(3-) multiple interactions ISO RGD:1614446 6480464 TRP53 protein affects the reaction [arsenite results in decreased expression of MYCN mRNA] CTD PMID:18929588 arsenous acid decreases expression ISO RGD:1344499 6480464 Arsenic Trioxide results in decreased expression of MYCN mRNA CTD PMID:12478894 , PMID:24685274 arsenous acid increases expression ISO RGD:1344499 6480464 Arsenic Trioxide results in increased expression of MYCN mRNA CTD PMID:20458559 benzo[a]pyrene affects methylation ISO RGD:1344499 6480464 Benzo(a)pyrene affects the methylation of MYCN 5' UTR CTD PMID:27901495 benzo[a]pyrene increases methylation ISO RGD:1344499 6480464 Benzo(a)pyrene results in increased methylation of MYCN exon, Benzo(a)pyrene results in increased methylation of MYCN promoter CTD PMID:27901495 benzo[a]pyrene decreases methylation ISO RGD:1614446 6480464 Benzo(a)pyrene results in decreased methylation of MYCN 3' UTR more ... CTD PMID:27901495 benzo[e]pyrene decreases methylation ISO RGD:1344499 6480464 benzo(e)pyrene results in decreased methylation of MYCN intron CTD PMID:30157460 bisphenol A affects expression ISO RGD:1344499 6480464 bisphenol A affects the expression of MYCN mRNA CTD PMID:20170705 bisphenol A increases expression ISO RGD:1344499 6480464 bisphenol A results in increased expression of MYCN mRNA CTD PMID:29275510 bisphenol A affects methylation ISO RGD:1614446 6480464 bisphenol A affects the methylation of MYCN promoter CTD PMID:27334623 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of MYCN mRNA CTD PMID:25181051 buta-1,3-diene decreases expression ISO RGD:1614446 6480464 1, 3-butadiene results in decreased expression of MYCN mRNA CTD PMID:29038090 butanal increases expression ISO RGD:1344499 6480464 butyraldehyde results in increased expression of MYCN mRNA CTD PMID:26079696 cadmium dichloride multiple interactions ISO RGD:1344499 6480464 [sodium arsenite co-treated with Cadmium Chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of MYCN mRNA CTD PMID:12634122 cannabidiol decreases expression ISO RGD:1344499 6480464 Cannabidiol results in decreased expression of MYCN mRNA CTD PMID:30713602 cannabidiol multiple interactions ISO RGD:1344499 6480464 [Cannabidiol results in increased expression of MIR1972-2 mRNA] which results in decreased expression of MYCN mRNA CTD PMID:30713602 carbon nanotube increases expression ISO RGD:1614446 6480464 Nanotubes, Carbon results in increased expression of MYCN mRNA CTD PMID:25554681 CGP 52608 multiple interactions ISO RGD:1344499 6480464 CGP 52608 promotes the reaction [RORA protein binds to MYCN gene] CTD PMID:28238834 chloroprene decreases expression ISO RGD:1614446 6480464 Chloroprene results in decreased expression of MYCN mRNA CTD PMID:23125180 choline multiple interactions ISO RGD:1614446 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of MYCN mRNA, [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of MYCN gene CTD PMID:20938992 cisplatin multiple interactions ISO RGD:1344499 6480464 [Cisplatin results in decreased susceptibility to Cisplatin] which results in increased expression of MYCN mRNA CTD PMID:30871063 clofibrate decreases expression ISO RGD:1614446 6480464 Clofibrate results in decreased expression of MYCN mRNA CTD PMID:25270620 cobalt dichloride decreases expression EXP 6480464 cobaltous chloride results in decreased expression of MYCN mRNA CTD PMID:24386269 coumarin increases phosphorylation ISO RGD:1344499 6480464 coumarin results in increased phosphorylation of MYCN protein CTD PMID:35688186 crizotinib multiple interactions ISO RGD:1344499 6480464 Crizotinib inhibits the reaction [ALK protein results in increased expression of MYCN mRNA], Crizotinib inhibits the reaction [ALK protein results in increased expression of MYCN protein] CTD PMID:22286764 crocin-1 decreases response to substance ISO RGD:1344499 6480464 MYCN results in decreased susceptibility to crocin CTD PMID:30672053 crocin-1 decreases expression ISO RGD:1344499 6480464 crocin results in decreased expression of MYCN protein CTD PMID:30672053 crocin-1 multiple interactions ISO RGD:1344499 6480464 crocin results in decreased expression of and results in decreased stability of MYCN mRNA more ... CTD PMID:30672053 Cuprizon increases expression EXP 6480464 Cuprizone results in increased expression of MYCN mRNA CTD PMID:26577399 deoxynivalenol affects phosphorylation ISO RGD:1614446 6480464 deoxynivalenol affects the phosphorylation of MYCN protein CTD PMID:23352502 diarsenic trioxide increases expression ISO RGD:1344499 6480464 Arsenic Trioxide results in increased expression of MYCN mRNA CTD PMID:20458559 diarsenic trioxide decreases expression ISO RGD:1344499 6480464 Arsenic Trioxide results in decreased expression of MYCN mRNA CTD PMID:12478894 , PMID:24685274 diazinon affects expression EXP 6480464 Diazinon affects the expression of MYCN mRNA CTD PMID:22546817 dibenz[a,h]anthracene increases expression ISO RGD:1614446 6480464 1 more ... CTD PMID:26377693 dichloroacetic acid decreases expression ISO RGD:1614446 6480464 Dichloroacetic Acid results in decreased expression of MYCN mRNA CTD PMID:28962523 dichromium trioxide multiple interactions ISO RGD:1344499 6480464 [sodium arsenite co-treated with Cadmium Chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of MYCN mRNA CTD PMID:12634122 dieldrin affects expression EXP 6480464 Dieldrin affects the expression of MYCN mRNA CTD PMID:22546817 diethyl maleate decreases expression ISO RGD:1614446 6480464 diethyl maleate results in decreased expression of MYCN mRNA CTD PMID:25270620 dioxygen decreases expression ISO RGD:1344499 6480464 Oxygen deficiency results in decreased expression of MYCN mRNA CTD PMID:26516004 dipotassium bis[mu-tartrato(4-)]diantimonate(2-) trihydrate multiple interactions ISO RGD:1344499 6480464 [MYCN protein affects the expression of ABCC1 mRNA] which affects the susceptibility to Antimony Potassium Tartrate CTD PMID:10348353 dipotassium bis[mu-tartrato(4-)]diantimonate(2-) trihydrate decreases response to substance ISO RGD:1344499 6480464 MYCN protein results in decreased susceptibility to Antimony Potassium Tartrate CTD PMID:10348353 dorsomorphin multiple interactions ISO RGD:1344499 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin multiple interactions ISO RGD:1344499 6480464 [MYCN protein affects the expression of ABCC1 mRNA] which affects the susceptibility to Doxorubicin CTD PMID:10348353 doxorubicin decreases response to substance ISO RGD:1344499 6480464 MYCN protein results in decreased susceptibility to Doxorubicin CTD PMID:10348353 entinostat increases expression ISO RGD:1344499 6480464 entinostat results in increased expression of MYCN mRNA CTD PMID:26272509 entinostat multiple interactions ISO RGD:1344499 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MYCN mRNA CTD PMID:27188386 ethanol multiple interactions ISO RGD:1614446 6480464 Ethanol affects the expression of and affects the splicing of MYCN mRNA CTD PMID:30319688 etoposide multiple interactions ISO RGD:1344499 6480464 [MYCN protein affects the expression of ABCC1 mRNA] which affects the susceptibility to Etoposide CTD PMID:10348353 etoposide decreases response to substance ISO RGD:1344499 6480464 MYCN protein results in decreased susceptibility to Etoposide CTD PMID:10348353 fenvalerate increases expression EXP 6480464 fenvalerate results in increased expression of MYCN mRNA CTD PMID:30307764 folic acid multiple interactions ISO RGD:1614446 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of MYCN mRNA, [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of MYCN gene CTD PMID:20938992 fonofos increases methylation ISO RGD:1344499 6480464 Fonofos results in increased methylation of MYCN promoter CTD PMID:22847954 furan increases methylation EXP 6480464 furan results in increased methylation of MYCN gene CTD PMID:22079235 genistein affects expression ISO RGD:1344499 6480464 Genistein affects the expression of MYCN mRNA CTD PMID:26865667 genistein increases expression ISO RGD:1614446 6480464 Genistein results in increased expression of MYCN mRNA CTD PMID:32186404 Heptachlor epoxide decreases expression ISO RGD:1614446 6480464 Heptachlor Epoxide results in decreased expression of MYCN mRNA CTD PMID:25270620 hydrogen cyanide decreases expression ISO RGD:1614446 6480464 Hydrogen Cyanide results in decreased expression of MYCN mRNA CTD PMID:33914522 isoprenaline decreases expression ISO RGD:1614446 6480464 Isoproterenol results in decreased expression of MYCN mRNA CTD PMID:20003209 isotretinoin decreases expression ISO RGD:1344499 6480464 Isotretinoin results in decreased expression of MYCN mRNA CTD PMID:17486130 isotretinoin multiple interactions ISO RGD:1344499 6480464 R116010 promotes the reaction [Isotretinoin results in decreased expression of MYCN mRNA] CTD PMID:17486130 ketamine decreases expression EXP 6480464 Ketamine results in decreased expression of MYCN mRNA CTD PMID:20080153 L-methionine multiple interactions ISO RGD:1614446 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of MYCN mRNA, [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of MYCN gene CTD PMID:20938992 lead diacetate multiple interactions ISO RGD:1344499 6480464 [sodium arsenite co-treated with Cadmium Chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of MYCN mRNA CTD PMID:12634122 leflunomide increases expression ISO RGD:1614446 6480464 leflunomide results in increased expression of MYCN mRNA CTD PMID:19751817 LY294002 multiple interactions ISO RGD:1344499 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [IGF1 protein results in increased expression of MYCN protein] CTD PMID:12569580 methapyrilene decreases methylation ISO RGD:1344499 6480464 Methapyrilene results in decreased methylation of MYCN intron CTD PMID:30157460 methylmercury chloride increases expression ISO RGD:1344499 6480464 methylmercuric chloride results in increased expression of MYCN mRNA CTD PMID:23179753 , PMID:26272509 methylmercury chloride multiple interactions ISO RGD:1344499 6480464 [NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MYCN mRNA CTD PMID:27188386 mono(2-ethylhexyl) phthalate decreases expression EXP 6480464 mono-(2-ethylhexyl)phthalate results in decreased expression of MYCN mRNA CTD PMID:16809437 mono(2-ethylhexyl) phthalate increases expression EXP 6480464 mono-(2-ethylhexyl)phthalate results in increased expression of MYCN mRNA CTD PMID:16809437 N,N-diethyl-m-toluamide multiple interactions EXP 6480464 [Permethrin co-treated with DEET] results in decreased methylation of MYCN gene CTD PMID:33148267 N-nitrosodiethylamine increases expression ISO RGD:1614446 6480464 Diethylnitrosamine results in increased expression of MYCN mRNA CTD PMID:24535843 N-nitrosodiethylamine multiple interactions ISO RGD:1614446 6480464 [Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of MYCN mRNA CTD PMID:24535843 nickel dichloride affects expression EXP 6480464 nickel chloride affects the expression of MYCN mRNA CTD PMID:22546817 ozone multiple interactions ISO RGD:1614446 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of MYCN mRNA, [Air Pollutants results in increased abundance of Ozone] which results in increased expression of MYCN mRNA CTD PMID:34911549 p-menthan-3-ol decreases expression ISO RGD:1344499 6480464 Menthol results in decreased expression of MYCN mRNA CTD PMID:26760959 panobinostat multiple interactions ISO RGD:1344499 6480464 (+)-JQ1 compound promotes the reaction [Panobinostat results in decreased expression of MYCN protein] more ... CTD PMID:26733615 , PMID:27188386 panobinostat increases expression ISO RGD:1344499 6480464 panobinostat results in increased expression of MYCN mRNA CTD PMID:26272509 panobinostat decreases expression ISO RGD:1344499 6480464 panobinostat results in decreased expression of MYCN protein CTD PMID:26733615 paracetamol decreases expression ISO RGD:1614446 6480464 Acetaminophen results in decreased expression of MYCN mRNA CTD PMID:17585979 paraquat decreases expression EXP 6480464 Paraquat results in decreased expression of MYCN mRNA CTD PMID:32680482 parathion increases methylation ISO RGD:1344499 6480464 Parathion results in increased methylation of MYCN promoter CTD PMID:22847954 PCB138 multiple interactions ISO RGD:1614446 6480464 [2 more ... CTD PMID:25510870 PCB138 decreases expression EXP 6480464 2 more ... CTD PMID:23829299 permethrin multiple interactions EXP 6480464 [Permethrin co-treated with DEET] results in decreased methylation of MYCN gene CTD PMID:33148267 phenobarbital multiple interactions ISO RGD:1614446 6480464 [Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of MYCN mRNA CTD PMID:24535843 phenobarbital decreases expression ISO RGD:1614446 6480464 Phenobarbital results in decreased expression of MYCN mRNA CTD PMID:23091169 potassium cyanide decreases expression ISO RGD:1614446 6480464 Potassium Cyanide results in decreased expression of MYCN mRNA CTD PMID:33914522 pregnenolone 16alpha-carbonitrile decreases expression ISO RGD:1614446 6480464 Pregnenolone Carbonitrile results in decreased expression of MYCN mRNA CTD PMID:28903501 progesterone multiple interactions ISO RGD:1344499 6480464 [Progesterone co-treated with Estradiol] results in decreased expression of MYCN mRNA CTD PMID:17404688 progesterone decreases expression ISO RGD:1614446 6480464 Progesterone results in decreased expression of MYCN mRNA CTD PMID:22238285 retinyl acetate increases expression ISO RGD:1614446 6480464 retinol acetate results in increased expression of MYCN mRNA CTD PMID:16772331 SB 431542 multiple interactions ISO RGD:1344499 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 silicon dioxide decreases methylation ISO RGD:1344499 6480464 Silicon Dioxide results in decreased methylation of MYCN gene, Silicon Dioxide results in decreased methylation of MYCN promoter CTD PMID:34973136 silver atom decreases expression ISO RGD:1614446 6480464 Silver results in decreased expression of MYCN mRNA CTD PMID:27131904 silver(0) decreases expression ISO RGD:1614446 6480464 Silver results in decreased expression of MYCN mRNA CTD PMID:27131904 sodium arsenate multiple interactions ISO RGD:1344499 6480464 [MYCN protein affects the expression of ABCC1 mRNA] which affects the susceptibility to sodium arsenate CTD PMID:10348353 sodium arsenate decreases response to substance ISO RGD:1344499 6480464 MYCN protein results in decreased susceptibility to sodium arsenate CTD PMID:10348353 sodium arsenite increases expression ISO RGD:1344499 6480464 sodium arsenite results in increased expression of MYCN mRNA CTD PMID:12016162 sodium arsenite affects methylation ISO RGD:1344499 6480464 sodium arsenite affects the methylation of MYCN gene CTD PMID:28589171 sodium arsenite decreases expression EXP 6480464 sodium arsenite results in decreased expression of MYCN mRNA CTD PMID:11241755 sodium arsenite multiple interactions ISO RGD:1344499 6480464 [sodium arsenite co-treated with Cadmium Chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of MYCN mRNA CTD PMID:12634122 sonidegib decreases response to substance ISO RGD:1344499 6480464 MYCN protein results in decreased susceptibility to sonidegib CTD PMID:24973920 sunitinib decreases expression ISO RGD:1344499 6480464 Sunitinib results in decreased expression of MYCN mRNA CTD PMID:31533062 terbufos increases methylation ISO RGD:1344499 6480464 terbufos results in increased methylation of MYCN promoter CTD PMID:22847954 testosterone multiple interactions EXP 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of MYCN mRNA CTD PMID:32741896 Testosterone propionate decreases expression ISO RGD:1614446 6480464 Testosterone Propionate results in decreased expression of MYCN mRNA CTD PMID:15601916 thapsigargin decreases expression ISO RGD:1344499 6480464 Thapsigargin results in decreased expression of MYCN mRNA CTD PMID:22378314 titanium dioxide decreases expression ISO RGD:1614446 6480464 titanium dioxide results in decreased expression of MYCN mRNA CTD PMID:29264374 Tributyltin oxide decreases expression ISO RGD:1614446 6480464 bis(tri-n-butyltin)oxide results in decreased expression of MYCN mRNA CTD PMID:25270620 trichostatin A decreases expression ISO RGD:1344499 6480464 trichostatin A results in decreased expression of MYCN mRNA CTD PMID:24935251 trichostatin A multiple interactions ISO RGD:1344499 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MYCN mRNA CTD PMID:27188386 trichostatin A increases expression ISO RGD:1344499 6480464 trichostatin A results in increased expression of MYCN mRNA CTD PMID:24935251 , PMID:26272509 triclosan increases expression ISO RGD:1344499 6480464 Triclosan results in increased expression of MYCN mRNA CTD PMID:30510588 trimellitic anhydride decreases expression ISO RGD:1614446 6480464 trimellitic anhydride results in decreased expression of MYCN mRNA CTD PMID:19042947 Tryptanthrine decreases expression ISO RGD:1344499 6480464 tryptanthrine results in decreased expression of MYCN mRNA, tryptanthrine results in decreased expression of MYCN protein CTD PMID:23500671 tunicamycin decreases expression ISO RGD:1344499 6480464 Tunicamycin results in decreased expression of MYCN mRNA CTD PMID:22378314 valproic acid increases methylation ISO RGD:1344499 6480464 Valproic Acid results in increased methylation of MYCN gene CTD PMID:29154799 valproic acid multiple interactions ISO RGD:1344499 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MYCN mRNA CTD PMID:27188386 valproic acid increases expression ISO RGD:1344499 6480464 Valproic Acid results in increased expression of MYCN mRNA CTD PMID:23179753 more ... valproic acid decreases expression ISO RGD:1344499 6480464 Valproic Acid results in decreased expression of MYCN mRNA CTD PMID:24935251 valproic acid decreases expression ISO RGD:1614446 6480464 Valproic Acid results in decreased expression of MYCN mRNA CTD PMID:19136453 more ... vincristine multiple interactions ISO RGD:1344499 6480464 [MYCN protein affects the expression of ABCC1 mRNA] which affects the susceptibility to Vincristine CTD PMID:10348353 vincristine decreases response to substance ISO RGD:1344499 6480464 MYCN protein results in decreased susceptibility to Vincristine CTD PMID:10348353 vismodegib decreases response to substance ISO RGD:1344499 6480464 MYCN protein results in decreased susceptibility to HhAntag691 CTD PMID:24973920 vorinostat multiple interactions ISO RGD:1344499 6480464 [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MYCN mRNA CTD PMID:27188386 vorinostat increases expression ISO RGD:1344499 6480464 vorinostat results in increased expression of MYCN mRNA CTD PMID:26272509 wortmannin multiple interactions ISO RGD:1344499 6480464 wortmannin inhibits the reaction [IGF1 protein results in increased expression of MYCN protein] CTD PMID:12569580